CHEMELLO, LILIANA
 Distribuzione geografica
Continente #
NA - Nord America 181
EU - Europa 175
AS - Asia 21
OC - Oceania 8
AF - Africa 3
Totale 388
Nazione #
US - Stati Uniti d'America 177
ES - Italia 42
FR - Francia 37
NL - Olanda 30
IT - Italia 18
GB - Regno Unito 12
CN - Cina 11
DE - Germania 9
NO - Norvegia 9
AU - Australia 8
BE - Belgio 6
CA - Canada 4
DK - Danimarca 4
JP - Giappone 3
CZ - Repubblica Ceca 2
GR - Grecia 2
HK - Hong Kong 2
SE - Svezia 2
TW - Taiwan 2
CM - Camerun 1
EG - Egitto 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
PL - Polonia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 388
Città #
Barcelona 23
Ashburn 20
Fairfield 17
Cerdanyola del Vallès 11
Bussum 10
Santa Cruz 10
Rennes 9
Madrid 8
Oslo 8
Padova 7
Amsterdam 6
Boardman 6
Houston 6
Seattle 6
Woodbridge 6
Beijing 5
Buffalo 5
Cambridge 5
Stanford 5
Bordeaux 4
Chicago 4
Des Moines 4
Maastricht 4
Melbourne 4
Palo Alto 4
Utrecht 4
Calgary 3
Cardiff 3
Columbus 3
Dallas 3
Gentofte 3
Herselt 3
Shanghai 3
Washington 3
Wilmington 3
Bideford 2
Boston 2
Chalandri 2
Duncan 2
Ferentino 2
Frankfurt am Main 2
Fremont 2
Kidlington 2
Lille 2
Los Angeles 2
New York 2
Portland 2
Taipei 2
Ann Arbor 1
Baghdad 1
Baton Rouge 1
Bologna 1
Cairo 1
Carlton North 1
Cassano delle Murge 1
Cedar Knolls 1
Clearwater 1
Eindhoven 1
Essex Junction 1
Esslingen am Neckar 1
Fort Worth 1
Fuzhou 1
Gdansk 1
Göttingen 1
Haacht 1
Hei- en Boeicop 1
Henderson 1
Herndon 1
Imaizumi 1
Kirkland 1
Kobe 1
Kontich 1
London 1
Los Altos 1
Milan 1
Milpitas 1
Muizenberg 1
New Orleans 1
Newcastle 1
Ottawa 1
Paris 1
Phoenix 1
Provo 1
Rijkevorsel 1
Riva 1
Rotterdam 1
Saint Petersburg 1
San Diego 1
San Francisco 1
San Jose 1
Scarsdale 1
Scranton 1
Seongbuk-gu 1
Sindelfingen 1
Stockholm 1
Suita 1
Tyresö 1
Vizille 1
Yellow Springs 1
Totale 305
Nome #
Modeling cost-effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real-life cohort, file e14fb26a-bb16-3de1-e053-1705fe0ac030 276
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals, file e14fb26f-9aa4-3de1-e053-1705fe0ac030 43
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study, file e14fb26a-bb57-3de1-e053-1705fe0ac030 23
Prognostic value of liver and spleen stiffness in patients with fontan associated liver disease (Fald): A case series with histopathologic comparison, file e14fb26e-6d9b-3de1-e053-1705fe0ac030 11
Role of transient elastography to stage fontan-associated liver disease (Fald) in adults with single ventricle congenital heart disease correction, file e14fb26f-b160-3de1-e053-1705fe0ac030 10
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis., file e14fb267-98ca-3de1-e053-1705fe0ac030 8
Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C., file e14fb267-a411-3de1-e053-1705fe0ac030 7
Relapse after direct-acting antivirals (DAAs) in cirrhotic patients with hepatitis C is highly related to development of liver cancer, file e14fb26a-bf62-3de1-e053-1705fe0ac030 6
Acute hepatitis C virus infection in a nurse trainee following a needlestick injury, file e14fb267-a222-3de1-e053-1705fe0ac030 3
Novel pharmacogenetic test for management of antiviral therapy in patients with chronic hepatitis C, file 8fd385dc-32bd-4255-8f3f-38c63489dc4b 2
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data, file 00d6d020-becb-498c-b7b6-41afa05dc902 1
Focal nodular hyperplasia of the liver: an emerging complication of hematopoietic SCT in children., file e14fb267-adc1-3de1-e053-1705fe0ac030 1
Totale 391
Categoria #
all - tutte 1.178
article - articoli 1.164
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.342


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202088 0 3 2 18 20 12 9 14 4 3 1 2
2020/202133 1 2 2 0 2 1 2 1 5 13 4 0
2021/202253 0 2 2 0 4 16 2 1 4 3 13 6
2022/202393 12 5 23 9 8 8 2 8 3 3 8 4
2023/2024119 48 8 13 5 17 9 4 8 5 1 1 0
Totale 391